| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 67.05B | 68.70B | 64.80B | 69.30B | 65.01B | 58.49B |
| Gross Profit | 13.14B | 13.94B | 13.04B | 13.61B | 14.97B | 15.12B |
| EBITDA | 2.58B | 2.36B | 3.05B | 3.54B | 3.89B | 4.64B |
| Net Income | -2.94B | 5.03B | 2.70B | 1.81B | 1.26B | 1.98B |
Balance Sheet | ||||||
| Total Assets | 98.03B | 97.70B | 101.22B | 103.02B | 103.15B | 100.46B |
| Cash, Cash Equivalents and Short-Term Investments | 10.78B | 8.05B | 8.36B | 12.85B | 10.59B | 12.16B |
| Total Debt | 4.53B | 1.51B | 9.06B | 10.96B | 18.78B | 14.91B |
| Total Liabilities | 24.90B | 20.18B | 27.38B | 30.48B | 35.01B | 32.54B |
| Stockholders Equity | 73.13B | 77.52B | 73.83B | 72.53B | 68.13B | 67.92B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.26B | -8.96B | 8.92B | -4.50B | 477.00M |
| Operating Cash Flow | 0.00 | 4.27B | -3.09B | 13.04B | -1.82B | 2.58B |
| Investing Cash Flow | 0.00 | 1.45B | 2.21B | -1.31B | -1.70B | 489.00M |
| Financing Cash Flow | 0.00 | -9.53B | -3.60B | -9.46B | 2.97B | 1.38B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥50.36B | 9.98 | ― | 2.12% | 6.02% | 101.02% | |
73 Outperform | ¥69.31B | 7.81 | ― | 1.55% | 6.02% | 5.87% | |
71 Outperform | ¥12.22B | 6.44 | ― | 1.91% | 1.42% | 29.11% | |
69 Neutral | ¥31.64B | 10.29 | ― | 2.84% | 1.00% | 15.35% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | ¥102.70B | -8.07 | ― | 3.97% | 0.74% | -35.11% | |
49 Neutral | ¥60.11B | 513.85 | ― | 1.14% | 9.13% | -21.27% |